Ziyan Pan

401 total citations
24 papers, 172 citations indexed

About

Ziyan Pan is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Ziyan Pan has authored 24 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 7 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in Ziyan Pan's work include Liver Disease Diagnosis and Treatment (17 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Diet, Metabolism, and Disease (4 papers). Ziyan Pan is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Diet, Metabolism, and Disease (4 papers). Ziyan Pan collaborates with scholars based in Australia, China and Saudi Arabia. Ziyan Pan's co-authors include Mohammed Eslam, Jacob George, Nahúm Méndez‐Sánchez, Jian‐Gao Fan, Brian Gloss, Gamal Esmat, Gamal Shiha, Martin Weltman, Duncan McLeod and Giada Sebastiani and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Ziyan Pan

17 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziyan Pan Australia 9 147 63 53 39 31 24 172
Hong Kai Lim United Kingdom 5 118 0.8× 49 0.8× 35 0.7× 39 1.0× 38 1.2× 10 158
Antonino Oliveri United States 7 127 0.9× 75 1.2× 33 0.6× 25 0.6× 20 0.6× 10 194
Sui‐Weng Wong Malaysia 6 133 0.9× 43 0.7× 69 1.3× 14 0.4× 23 0.7× 6 170
Kensuke Munekage Japan 7 120 0.8× 63 1.0× 48 0.9× 11 0.3× 22 0.7× 12 144
Anne Linde Mak Netherlands 8 152 1.0× 50 0.8× 82 1.5× 32 0.8× 57 1.8× 13 210
Anita Arslanow Germany 6 248 1.7× 80 1.3× 165 3.1× 36 0.9× 16 0.5× 16 279
Sulav Shrestha Canada 4 214 1.5× 111 1.8× 97 1.8× 25 0.6× 28 0.9× 8 249
Leigh Alexander Greece 3 82 0.6× 31 0.5× 33 0.6× 11 0.3× 25 0.8× 3 131
Johanne Kragh Hansen Denmark 7 246 1.7× 88 1.4× 134 2.5× 21 0.5× 20 0.6× 13 276
Jonathon Marioneaux India 3 78 0.5× 37 0.6× 16 0.3× 18 0.5× 43 1.4× 4 104

Countries citing papers authored by Ziyan Pan

Since Specialization
Citations

This map shows the geographic impact of Ziyan Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyan Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyan Pan more than expected).

Fields of papers citing papers by Ziyan Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyan Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyan Pan. The network helps show where Ziyan Pan may publish in the future.

Co-authorship network of co-authors of Ziyan Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyan Pan. A scholar is included among the top collaborators of Ziyan Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyan Pan. Ziyan Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alqahtani, Saleh A., Wai‐Kay Seto, Yusuf Yılmaz, et al.. (2025). Alternative splicing: hallmark and therapeutic opportunity in metabolic liver disease. Gastroenterology report. 13. goaf044–goaf044.
2.
Pan, Ziyan, Khalid Al‐Naamani, Moutaz Derbala, et al.. (2025). Changing profile and burden of hepatocellular carcinoma in Arab Countries in 1990–2021. Annals of Hepatology. 30(2). 102104–102104.
3.
Alem, Shereen Abdel, et al.. (2025). Differential risk factors of fibrosis between lean and obese MAFLD. Clinical and Experimental Medicine. 25(1). 211–211.
4.
5.
6.
Pan, Ziyan, Lawrence Yuen, Christopher B. Nahm, et al.. (2025). Characterisation of non-cirrhotic MAFLD-related hepatocellular carcinoma: a retrospective cohort study. Therapeutic Advances in Chronic Disease. 16. 404387978–404387978.
7.
Pan, Ziyan, Saleh A. Alqahtani, Said A. Al‐Busafi, et al.. (2025). Underrepresentation of Arabs in Functional Genetics Studies: Opportunities and Obstacles for Advancing Biology and Human Health. Liver International. 45(5). e70088–e70088. 2 indexed citations
8.
Pan, Ziyan, Petr Hědenec, Qiang Lin, et al.. (2024). Dynamics and resilience of earthworm fecal microbiomes under distinct feeding regimes. Applied Soil Ecology. 206. 105846–105846.
9.
Pan, Ziyan, et al.. (2024). MERTK and Fibrosis: A New Target for Therapy. DNA and Cell Biology. 43(7). 311–314. 1 indexed citations
10.
Pan, Ziyan, Ali Bayoumi, Brian Gloss, et al.. (2024). Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease. Science Translational Medicine. 16(741). eadj0133–eadj0133. 15 indexed citations
11.
Pan, Ziyan, et al.. (2024). Exportin 4 DNA promoter methylation in liver fibrosis. PLoS ONE. 19(5). e0302786–e0302786. 1 indexed citations
12.
Pan, Ziyan, et al.. (2024). A Cell Specific Effect of MBOAT7 MAFLD-risk Variant on Immune Cells. Frontiers in Bioscience-Landmark. 29(4). 148–148. 1 indexed citations
13.
Pan, Ziyan, et al.. (2024). MAFLD identifies patients with significant hepatic fibrosis better than MASLD. Hepatology International. 18(3). 964–972. 14 indexed citations
14.
Pan, Ziyan, et al.. (2024). A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact. HepatoBiliary Surgery and Nutrition. 13(4). 650–661. 3 indexed citations
15.
Wang, Ruizhen, Xue Bai, Jingzhou Wang, et al.. (2024). Integrated analysis reveals that miR-548ab promotes the development of obesity and T2DM. Journal of genetics and genomics. 52(2). 231–244.
16.
Pan, Ziyan, Moutaz Derbala, Khalid Al‐Naamani, et al.. (2024). MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease. Annals of Hepatology. 29(5). 101512–101512. 17 indexed citations
17.
Pan, Ziyan, Gamal Shiha, Gamal Esmat, Nahúm Méndez‐Sánchez, & Mohammed Eslam. (2024). MAFLD predicts cardiovascular disease risk better than MASLD. Liver International. 44(7). 1567–1574. 27 indexed citations
18.
Pan, Ziyan, Brian Gloss, Duncan McLeod, et al.. (2023). Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming. Metabolism. 144. 155583–155583. 23 indexed citations
19.
Bayoumi, Ali, Khaled Thabet, Ziyan Pan, et al.. (2022). A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes. Nature Communications. 13(1). 7430–7430. 29 indexed citations
20.
Pan, Ziyan, Jian‐Gao Fan, & Mohammed Eslam. (2021). An update on drug development for the treatment of metabolic (dysfunction) associated fatty liver disease: Progress and opportunities. Current Opinion in Pharmacology. 60. 170–176. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Kai Lim Breakdown of academic impact, for papers by Antonino Oliveri Breakdown of academic impact, for papers by Sui‐Weng Wong Breakdown of academic impact, for papers by Kensuke Munekage Breakdown of academic impact, for papers by Anne Linde Mak Breakdown of academic impact, for papers by Anita Arslanow Breakdown of academic impact, for papers by Sulav Shrestha Breakdown of academic impact, for papers by Leigh Alexander Breakdown of academic impact, for papers by Johanne Kragh Hansen Breakdown of academic impact, for papers by Jonathon Marioneaux
Rankless by CCL
2026